Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

Cite

CITATION STYLE

APA

Nordkin, I., Levinas, T., Rosenfeld, I., & Halabi, M. (2021). Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation. Clinical Case Reports, 9(1), 391–394. https://doi.org/10.1002/ccr3.3539

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free